Despite the healthcare ecosystem’s push for transparency, there remains a shroud of secrecy around one ubiquitous healthcare treatment tool: prescription drugs. No one — not doctors, not insurers and certainly not patients — know what they really cost.
popdevteamTech Can Solve A Stubborn Problem: Medication Adherence
The industry has been criticized for lack of transparency—and worse. Some see ‘a ton of sense’ in the proposed mergers with insurers and retailers. Others see a risk of even higher drug prices and a need for oversight.
popdevteamPBMs: Maligned as Middlemen, They’re Hearing Wedding Bells
The Trump administration unveiled on Friday what it had termed a bold blueprint to address ever-rising drug prices in the United States, but it was mostly a collection of modest, pro-pharmaceutical industry proposals that would nibble at the margins of the issue and likely put more fiscal pressure on hospitals.
popdevteamTrump’s Blueprint on Drug Price Reform Arrives; Hospitals’ Use of 340B Program Comes Under Scrutiny